However, the exact anti-cancer mechanism of ACT001 remains controversial, as it was identified as a direct inhibitor of plasminogen activator inhibitor-1 (PAI-1) and exerted anti-cancer effects in glioma cells by inhibiting the PAI-1/PI3K/AKT pathway [279]. Here, SERPINE1 is linked to central nervous system cancer.